Sutro Biopharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| STRO | VRXA | CHRS | HBP.TO | MGNX | PYXS | |
|---|---|---|---|---|---|---|
| Market cap | 164.82M | 134.34M | 131.36M | 70.27M | 147.15M | 198.30M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.6 | — | -1.3 | -8.4 | -1.6 | -1.5 |
| Price/book | -1.6 | -0.7 | 2.2 | 4.8 | 3.4 | 9.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −2.96% | −90.96% | −42.95% | −54.68% | +61.81% | −58.06% |
| Today | +4.52% | −4.04% | +5.54% | 0.00% | −0.86% | +1.22% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All STRO news ›Sutro Biopharma (NASDAQ:STRO) Stock Rating Upgraded by Wall Street Zen
Posted by Tristan Rich on Oct 31st, 2026 Sutro Biopharma (NASDAQ:STRO – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report released on Saturday, Wall…
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
SCHMID Group Reaches Agreement on Significant Equipment Order to Support HDI Capacity Expansion in Malaysia INVE Technologies Announces the Commencement of a $20 Million Modified Dutch Auction Tender Offer for its Common Stock Nexera…
Protagonist Therapeutics (NASDAQ:PTGX) & Sutro Biopharma (NASDAQ:STRO) Financial Review
Posted by Tristan Rich on Oct 20th, 2026 Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) and Sutro Biopharma (NASDAQ:STRO – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two…
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
Antibody drug conjugates are targeted medicines that combine an antibody, which seeks out specific markers on diseased cells, with a powerful drug that is released only when the antibody binds its target. Think of it as a guided missile…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.